Mutagenesis by the human bladder carcinogen 4-aminobiphenyl (ABP) was studied in single-stranded DNA from a bacteriophage M13 cloning vector. In comparison to ABP lesions in double-stranded DNA, lesions in single-stranded DNA were~70-fold more mutagenic and 50-fold more genotoxic. Sequencing analysis of ABP-induced mutations in the lacZ gene revealed exclusively base-pair substitutions, with over 80% of the mutations occurring at G sites; the G at position 6310 accounted for 25% of the observed mutations. Among the sequence changes at G sites, G→T transversions predominated, followed by G→C transversions and G→A transitions. In order to further elucidate the mutagenic mechanism of ABP, an oligonucleotide containing the major DNA adduct, N-(deoxyguanosin-8-yl)-4-aminobiphenyl (dG 8-ABP ), was situated within the PstI site of a single-stranded M13 genome. After in vivo replication of the adduct containing ABP-modified and control (unadducted) genomes, the mutational frequency and mutational specificity of the dG 8-ABP lesion were determined. The targeted mutational efficiency was~0.01%, and the primary mutation observed was the G→C transversion. Thus dG 8-ABP , albeit weakly mutagenic at the PstI site, can contribute to the mutational spectrum of ABP lesions.
Introduction
The aromatic amine, 4-aminobiphenyl (ABP*), is considered to be a potent human carcinogen (1, 2) , based on epidemiological studies of bladder cancer among workers with industrial exposure. ABP exposure also occurs in a large number of people both directly and passively, through exposure to cigarette smoke and perhaps other environmental sources. With the development of sensitive methods for detection of ABP in the blood and in DNA, molecular epidemiologic studies have been carried out in human populations (3, 4) . These studies have established that ABP residues are found in hemoglobin and in DNA isolated from the urothelium, potentially implicating ABP in the etiology of cancer of the bladder. Extensive data on human exposure and metabolism of ABP in animal models are available, yet little information exists concerning the mechanisms underlying its genotoxic and mutagenic effects. The mechanism by which exposure to ABP may lead to bladder and other cancers is probably initiated by the mutagenic activity of the carcinogen. Thus, it is crucial to understand the impact of ABP on the genome and how organisms process ABP lesions.
The ABP lesion first identified in human DNA (2, 4) on the basis of co-chromatography with a synthetic standard, and later confirmed by GC/MS (5) , was N-(deoxyguanosin-8-yl)-4-aminobiphenyl (dG ). This adduct is the major carcinogen-DNA product observed following treatment of DNA with Nhydroxy (N-OH) ABP or dosing of dogs with ABP (6,7), representing~70% of the binding in vivo. Two other lesions, N-(deoxyguanosin-N 2 -yl)-4-aminobiphenyl and N-(deoxyadenosin-8-yl)-4-aminobiphenyl, accounted for~15% and 10% of the binding, respectively. Initial computational studies of dG 8-ABP adducts in one DNA sequence indicated that the aminobiphenyl moiety resides in the major groove (8) , and it has been proposed that binding of ABP lesions to DNA in a poly (dG·dC) sequence causes a slight B-Z transition. An NMR study (9) of a dG 8-ABP adduct revealed major and minor conformers. The major conformer had the bound biphenyl residue in the major groove; the placement of the aromatic system of the minor conformer was not identified, although intercalation or minor groove placements were proposed. Shapiro et al. (10) calculated that, for dG 8-ABP , sequence context determined whether the major or minor groove conformers were more stable; in contrast, for dA 8-ABP the minor groove adducts were invariably more stable. Low energy syn conformers, due to rotation of the glycosidic bond, have been proposed to be mutagenic in the course of DNA replication (8) .
Mutagenesis by ABP has been studied in bacterial and eukaryotic systems. Studies in Salmonella typhimurium (11) (12) (13) (14) (15) , employing either ABP plus a metabolizing system or N-OH-ABP, established that mutagenesis could be enhanced in the presence of SOS-processing functions, as provided by pKM101. Frameshift and base-pair substitution mutations were detected at both G:C and A:T base-pair targets. In Escherichia coli (E.coli) viral or plasmid systems (14, 16, 17) , mutations due to ABP lesions have generally occurred at a low level, with G residues the principal targets for base substitution mutations. Following treatment of E.coli with N-OH-ABP, it was observed that adducts persisted in excision repair deficient strains as compared with wild-type strains (18) . In the L5178Y TK ϩ/-mouse lymphoma forward mutation assay, ABP activated by a liver S-9 fraction induced TK -/-mutations (19) .
An important objective of our study was to address the question of the mutational specificity of ABP-DNA lesions. Consequently, we undertook a study of mutagenesis in the E.coli lacZα gene using M13 cloning vectors. This system, which has been widely employed in mutagenicity and polymerase fidelity assays (20, 21) , is capable of detecting many basepair substitution mutations, as well as most insertions and deletions. Among DNA lesions caused by aromatic amines evaluated in the lacZα forward mutation assay are ABP-DNA adducts (14) , 2-aminofluorene (AF)-DNA adducts (22) and N-acetoxy-2-acetylaminofluorene (AAF)-DNA adducts (23) . These mutation assays may utilize double-or single-stranded phage genomes. In our present study, mutagenicity experiments were performed using single-stranded DNA in order to minimize the effect of host DNA repair processes. In one series of experiments, carcinogen-DNA lesions were introduced into the complete phage genome while, in a second set of experiments, a deoxyguanosine residue within the PstI recognition sequence was replaced by a single dG lesion to analyze the genotoxic consequences of this adduct in vivo.
Materials and methods

Chemicals, DNA standards and primers
Acetic anhydride, 4-nitrobiphenyl, pyruvonitrile, triethylamine and trifluoroacetic (TFA) anhydride were purchased from Aldrich Chemical Co. (Milwaukee, IL) N-Hydroxy-aminobiphenyl (2,2Ј-[ 3 H], 92 mCi/mmol) was purchased from Midwest Research Institute (Kansas City, MO). Reagents for synthesis of deoxyoligonucleotides were obtained from Applied Biosystems (Foster City, CA). HPLC solvents were Omnisolv from EM Science (Gibbstown, NJ). Adenosine triphosphate (ATP), Sepharose CL-4B resin, and ethidium bromide were purchased from Sigma Chemical Co. (St Louis, MO) DNA-grade hydroxylapatite (HAP), 5-bromo-4-chloro-3-indolyl-β-Dgalactopyranoside (X-gal) and isopropyl β-D-thiogalactopyranoside (IPTG) were purchased from Boehringer Mannheim Biochemicals (Indianapolis, IN). Radionuclides [γ 32 P]ATP (6000 Ci/mmol) and [α 35 S]ATP (600 Ci/mmol) were obtained from Dupont/New England Nuclear (Boston, MA) and Amersham Corporation (Arlington Heights, IL), respectively. Acrylamide, Bio-Gel A agarose resin, and polyacrylamide resin P4 were from Bio-Rad Laboratories (Richmond, CA). Pharmacia LKB Biotechnology (Piscataway, NJ) was the source for the 8-32 base oligonucleotide molecular weight markers. The M13 lacZ gene 17-base sequencing primer was synthesized at the Whitehead Institute for Biomedical Sciences (Cambridge, MA). The M13 cloning region 15-base primer was purchased from New England Biolabs (Beverly, MA). The M13 '-40' 17-base sequencing primer was purchased from Pharmacia LKB Biotechnology and also from the United States Biochemical Corporation (Cleveland, OH). The 15-base oligonucleotides used for the hybridization analysis were synthesized in the Biopolymers Laboratory (MIT, Cambridge, MA).
Enzymes
Exonuclease III was purchased from Gibco BRL (Gaithesberg, MD). DNA restriction enzymes PstI, SmaI, and BglII were purchased from Boehringer Mannheim Biochemicals (Indianapolis, IN) or New England Biolabs. E.coli DNA polymerase I (Klenow fragment), calf intestinal alkaline phosphatase (CIP), bacteriophage T4 polynucleotide kinase, and T4 DNA ligase were purchased from Boehringer Mannheim Biochemicals.
Bacterial strains E.coli strains derived from AB1157 were used in mutagenesis assays (14) : excision repair-proficient E.coli DL7 (AB1157, lac nU169, uvr ϩ ), and excision repair-deficient E.coli DL6 (AB1886, lac nU169, uvrA). In some experiments, E.coli DL7/pGW16 cells harboring the mutagenesis-enhancing plasmid, pGW16 [a derivative of pKM101 (24) ], were used. Other strains used for transfections and plating were MM294A (obtained from K. Backman), GW5100 (JM103 P1 -, obtained from L. Marsh), and NR8044 (lacZ∆M15, M13 plating strain, opal suppressor, obtained from R. Dunn).
DNA purification M13 bacteriophage ss DNA was prepared by a modified protocol of Messing (25) . The single-stranded (ss) DNA was further purified over a HAP column and stored in TE (10 mM Tris-Cl, 1.0 mM EDTA pH 8.0) at 4°C. M13 RF DNA was isolated from the phage-infected bacteria using a modified version 2404 of the Triton-lysis procedure (26) . For analysis of M13 mutant phage samples, small-scale preparations of M13 ss and RF DNA were made. A late-log phase culture of E.coli GW5100 was diluted 1:100 in 2ϫ YT medium and inoculated with a single M13 phage plaque; it was then grown for 3 h at 37°C. The cells were pelleted and M13 RF DNA was isolated according to a modified alkaline lysis protocol (26) , and M13 ss DNA was purified as described (25) .
Preparation of globally ABP-modified M13 genomes N-OAc-TFAABP was synthesized from N-OH-ABP (2,2Ј-[ 3 H]) by the method of Lee and King (27) . M13mp10 ss DNAs (7244 bases) were randomly adducted with 20 mM N-OAc-TFAABP (sp. act. 7.85 mCi/mmol). Reaction conditions were 300 µg/ml M13 ss DNA in TE at 37°C for 1 h. M13mp10 RF DNA (7244 bp) was treated with N-OAc-TFAABP under the same conditions, except that the DNA concentration was 200 µg/ml. A total of 200 to 300 µg of each type of DNA and a total of three dose points including a buffer control was done for each modification experiment. Samples of DNA were subjected to n-butanol and phenol extractions to remove N-OAc-TFAABP decomposition products and the modified DNAs were stored in ethanol at Ϫ70°C. As a standard, calf thymus DNA modified with N-OAc-TFAABP under similar conditions, was hydrolyzed and analyzed by HPLC to determine the distribution of adducts and the adduct profile of DNA binding by the activated ABP derivative. Extent of modification, expressed as the number of [ 3 H]ABP residues bound to DNA, was determined by measuring the amount of radioactive material present in a known amount of DNA and calculating the number of adducts present. The number of apurinic/apyrimidinic (AP) sites in M13mp10 RF DNA possibly caused by the reaction conditions was assessed by the method of Drinkwater et al. (28) . In order to judge the integrity of the M13 ss DNA and estimate the number of putative AP sites that may have formed after the modification reaction, M13 ABP-modified ss DNA was treated with 0.1 M NaOH and electrophoresed through 1.0% agarose gels in 1X TBE (89 mM Tris-borate, 2 mM EDTA) buffer, followed by staining with ethidium bromide.
Mutagenesis experiments with globally adducted M13-ABP-DNA
M13 ss and RF DNAs randomly modified with ABP were transfected into E.coli cells made competent for uptake of exogenous DNA by a calcium chloride protocol, as described previously (14) . In experiments involving SOS processing, half the culture (DL7 or DL7/pGW16 cells) was subjected to UV irradiation for 40 s with a 15 W General Electric germicidal lamp at a UV fluence rate of 1.1 J/m 2 per s. A 40-min growth period was included to allow for expression of SOS gene products. DL6 (uvrA) cells were treated with UV for 6 s and subsequently incubated for 20 min to allow expression of SOS gene products. The cells were then made competent for DNA uptake as described above, placed on ice, and used immediately for transfection of modified DNAs.
In transfection experiments using ss DNAs, 50 ng of the buffer control DNA, 100-750 ng of modified ss DNA, or 1 ng untreated control DNA in a volume of 100 µl was added to 200 µl of competent cells (4ϫ10 8 ) per transfection. In experiments employing RF DNAs, 40 ng of RF-modified DNA or 1 ng buffer control DNA was used per transfection. Transfections were carried out as described (29) . Transfection efficiency (survival) of the modified genomes was estimated by enumerating infective centers produced after plating the transfection mixture and comparing this number to the actual amount of DNA used per transfection. Mutations were scored as colorless or pale blue plaques on X-gal indicator plates (14) , and mutation frequency was determined by dividing the number of mutant phage by the total number of infective centers obtained after the transfection. Putative mutant phage were plaque-purified by restreaking on new plates and small-scale preparations of M13 ss DNA were obtained for sequence analysis. M13 ss DNAs were sequenced by the dideoxy method (30) (31) , which was subsequently N-acetylated in a 1 h reaction at -45°C with pyruvonitrile and triethylamine (32, 33) . A 10 µmol portion of TGCA was dissolved in 30 ml chloroform:ethyl alcohol:H 2 O (7:4:4) and triethylamine (1 ml), and was allowed to react with five sequential additions of solid N-OAc-ABP (total 3.78 mmol) at 25°C. After 3 h, the reaction was diluted with dichloromethane and water, the aqueous layer was collected and washed with dichloromethane and finally the sample was concentrated to dryness in vacuo. The crude mixture was purified on a preparative reversed phase HPLC system equipped with a Hewlett Packard 1040A diode-array detector using a linear gradient from 0-50% CH 3 CA] were then examined on a reversed phase Phenomenex Ultramex 5-µm C18 column (25ϫ0.46 cm) using a Beckman HPLC system. After purification, the tetramers were desalted using the same HPLC column and a linear H 2 O-CH 3 CN gradient. The tetramers were characterized during HPLC purification by UV absorbance at 260 nm and 310 nm (the latter wavelength corresponds to a characteristic chromophore of aromatic amine-substituted DNA species), using the diode array detector, to confirm the structural integrity of the ABP-adducted oligonucleotide (34) .
Following purification, aliquots of the modified and unmodified tetranucleotides were digested sequentially with nuclease P1 for 12 h at 37°C in 10 mM ZnSO 4 , 30 mM NaOAc (pH 5.2), followed by snake venom phosphodiesterase for 3-4 h at 37°C in 100 mM Tris-HCl (pH 8.0), 10 mM MgCl 2 . The nucleoside digestion products were analyzed on a C18 reversed phase column using a gradient from 0 to 50% CH 3 CN in 0.1 M NH 4 OAc, pH 7.2.
Both unmodified and ABP-modified oligonucleotides were 5Ј-end labeled with [γ 32 P]ATP and T4 polynucleotide kinase. The radiolabeled tetranucleotides were then denatured at 100°C and electrophoresed on 23% polyacrylamide gels to assess the purity and integrity of the samples. Unlabeled control and ABP-modified tetranucleotides were denatured under the same conditions and analyzed by UV spectroscopy and HPLC to assess the chemical stability of the tetramers following denaturation.
Construction of a site-specifically modified M13 genome containing the major dG 8-ABP adduct at a unique PstI restriction enzyme site
Gapped heteroduplex (GHD) vector (M13GHD) was prepared from a pair of M13mp19 derived vectors (obtained from E.Loechler) according to a modification of the protocol of Green et al. (35) . RF DNA (50 µg) prepared from M13mp19(ϩ6) was linearized by SmaI restriction enzyme digestion and annealed with 50 µg of M13mp19(ϩ10) DNA (containing a unique PstI site) previously linearized by BglII and 5Ј dephosphorylated with CIP. To form GHD molecules, the linearized DNA was incubated at 100°C for 5 min, then 65°C for 30 min, and then slowly cooled to room temperature. An aliquot of the mixture was analyzed by agarose gel electrophoresis to determine the proportion of M13GHD. The M13GHD vectors were freshly prepared and stored in aqueous solution at 4°C until the ligation step. It is important to note that two forms of GHD were in the mixture, those with a unique fourbase gap at the PstI site in the plus strand of the M13DNA and a nick at the BglII site in the minus strand, and those with the four-base gap in the minus strand and the nick in the plus strand of the viral genome.
The tetranucleotides 5Ј-d[TpG 8-ABP CA]-3Ј and 5Ј-d[TGCA]-3Ј were 5Ј phosphorylated and ligated into the gapped heteroduplex vectors. Tetramers (100 pmol in pilot experiments) were incubated in 10 µl with 100 µCi of [γ 32 P]ATP (6000 Ci/mmol) and unlabeled ATP for a total ATP concentration of 50 µM, 50 mM Tris-HCl (pH 7.4), 10 mM MgCl 2 , 5 mM DTT, and T4 polynucleotide kinase. An aliquot of the reaction mixture was analyzed on a 23% polyacrylamide, 7 M urea gel run in 1ϫ TBE, exposed to a solid phosphor screen, and analyzed on a Molecular Dynamics PhosphorImager. The region of gel containing the oligonucleotide was excised and counted in a liquid scintillation counter to determine the specific activity as c.p.m./pmol of oligonucleotide. The ABP-adducted and the control 32 P-labeled tetramers (100 pmol) were incubated with 0.2 pmol (1 µg) M13GHD DNA for the ligation reactions, which were carried out with either E.coli DNA ligase (16 h at 12°C in 20 mM Tris-HCl (pH 7.5) buffer, 4 mM MgCl 2 , 10 mM (NH 4 ) 2 SO 4 , 0.1 M KCl, 0.1 mM NAD ϩ ) or T4 DNA ligase (16 h at 16°C in 50 mM Tris-HCl (pH 7.8) buffer, 10 mM MgCl 2 , 10 mM dithiothreitol, 1 mM ATP). Ligated genomes were purified by chromatography (0.7ϫ20 cm column containing Sepharose CL 4B or BioRad Bio-Gel A desalting gel) or by centrifugation in a Centricon-10 microconcentrator (Amicon Corporation) to remove unincorporated radiolabeled tetramer.
Ligation efficiency represented the percentage of M13GHD molecules that had incorporated a phosphorylated tetramer. The ABP-modified genome was digested with restriction endonucleases to confirm the location of the adduct in the genome. The unmodified genome was digested in parallel as a control, and the samples were electrophoresed through a 0.8% agarose gel containing ethidium bromide. The gels were photographed and then dried at 60°C on a gel dryer and exposed to X-ray film overnight with an intensifying screen or exposed to a PhosphorImager screen to visualize the radiolabeled genomes. The modified and control genomes were also heat denatured (100°C for 5 min) and electrophoresed through 1% agarose gels that were subsequently stained with ethidium bromide.
Preparation of M13 genomes for transfection
The DNA from both sets of vectors was digested with SmaI, and the ABPmodified DNA was further digested with PstI to ensure removal of any PstIsensitive material from the sample. The digested samples were extracted with 2405 phenol:chloroform, then chloroform, and then subjected to three washes with TE in a Centricon-10 microconcentrator.
Transfection assays with a singly-adducted M13 genome in E.coli
In order to prepare bacterial cells for transfection, a 1:100 dilution of an overnight culture was grown in LB medium to mid-log phase, usually 1-2ϫ10 8 cells/ml. The cells were pelleted and resuspended in an equal volume of sterile, cold 10 mM MgSO 4 . Cells to be induced for SOS gene functions (DL7/pGW16) were exposed for 40 s to a germicidal lamp, as described above. The cells were then added to an equal volume of 2ϫ LB and incubated at 37°C for 40 min for expression of SOS gene products. Both flasks of cells were placed on ice and prepared and washed with H 2 O to remove particulates. The control and adduct-containing genomes were heat denatured (100°C for 5 min) to generate ss genomes and then placed on ice to prevent strand renaturation. For each transfection, 40 µl of cells were placed in microfuge tubes containing~100 ng of the denatured genomes. In experiment 1, 72 ng of control and 120 ng of adducted genome were transfected into DL7: UV cells and 78 ng of control and 130 ng of adducted genome was transfected into DL7/pGW16 ϩ UV cells, and in experiment 2, 110 ng of control or adducted DNA was used in each transfection. The mixture was then transferred to a cold Gene Pulser cuvette and electroporated with a Bio-Rad Gene Pulser electroporation system at 2.5 kV, 25 µF and 200 ohms with an average time constant of 4.7 s (36). Immediately after electroporation, 1 ml of SOC medium was added to the transfection mixture and the samples were removed from the cuvette to a sterile culture tube. Aliquots of the mixture were plated on B broth, X-gal, IPTG indicator plates with an M13 host E.coli GW5100 followed by enumeration of infective centers to determine efficiency of transfection of the genomes (survival). Progeny phage were produced by incubating the transfection tube at 37°C for 2 h. Progeny phage from the initial transfection were subsequently analyzed for mutants.
Detection of mutants
The first protocol was selection for inactivation of the PstI restriction enzyme recognition site essentially as described by Loechler et al. (21) , but with omission of the exonuclease III step used previously (14, 21) . The RF DNA was isolated from the progeny phage produced in the transfection. RF DNA was initially subjected to restriction by PstI enzyme (25 units for 10 µg RF DNA) to linearize wild-type RF DNA and subsequently transformed into E.coli MM294A cells made competent by the CaCl 2 method. This protocol was based on two assumptions: first, adduct induced mutations at the PstI site rendered mutant progeny resistant to this enzyme and second, linear RF DNA transforms at a very low efficiency (Ͻ1% compared with circular RF DNA). Rounds of mutant selection were continued until there was no further increase in the relative number of PstI resistant phage. In these experiments, three rounds of PstI selection were performed, for a total of four transformations (T 1 ,T 2 ,T 3 ,T 4 ). After this selective procedure, putative mutant phage were isolated for sequence analysis at, and in the vicinity of, the PstI site. The mutational frequency (MF), defined as the frequency of mutants among the progeny phage, was determined by enumerating the number of blue mutant progeny phage from the final transformation and dividing that value by the total number of phage from the initial transformation. A colorless plaque phenotype was used as an internal standard to correct for transformation efficiency (14, 21, 36) .
The formula used was the following: MF ϭ (M/seq B 4 )ϫ(B 4 /C 4 )ϫ(C 1 / T 1 )ϫ100. In these calculations, M represented the mutant blue phage (as confirmed by DNA sequencing) obtained after the final transformation (T 4 ). Targeted mutant blue phage (M Tar ) were defined as occurring at the location of the lesion in the PstI site (positions 6245 and 6246). Untargeted mutant blue phage (M Un ) as determined by DNA sequencing were insertion or deletion mutations and base-pair substitution mutations at positions 6243, 6244, 6247 or 6248 of the PstI site. The number of total mutant blue phage (M Tot ) was M Tar plus M Un . The value for seq B 4 was the number of blue plaques from the final transformation that were sequenced (M Tot plus the number of phage that were wild type at the PstI site and had evaded the selection scheme) and ranged from 21 to 60 phage for each data point; B 4 equaled the total blue phage after the final transformation; C 4 represented the number of colorless plaques in the final transformation; C 1 was the number of colorless plaques observed from the first transfection; and T 1 was the total number of progeny phage produced from the initial transfection. A sample calculation is shown in Table II .
Differential hybridization was a second method employed for detection of mutant bacteriophage. After transfection, phage from a plaque were transferred by stippling in a grid onto a new plate that had an overlay of E.coli strain NR8044 grown for 2 h. The plaques from the grid were lifted with a 137-mm dry nitrocellulose filter (Schleicher and Schuell). The filters were airdried and baked for 30 min on a vacuum gel dryer at 80°C. The filters were screened with a 15 base 5Ј-[ 32 P]-end-labeled oligonucleotide, 5Ј-CGCCCTGCAGGGCAA-3Ј, that had a complementary sequence to the wild- Mutation frequency (MF) was determined by dividing the number of mutant plaques by the total number of plaques (infective centers). Relative MF is the MF above background as determined with buffer and solvent control DNA containing 0 adducts per genome. DL7 cells are excision repair proficient. Ultraviolet light treatment was performed as described in the Materials and methods section.
type phage DNA at the PstI restriction site. Hybridization conditions were 6ϫ SSPE (26), 10% dextran sulfate, 0.5% sodium pyrophosphate, 0.1% SDS, and 100 µg/ml sonicated calf thymus DNA with a probe concentration of 8 ng/ml at 1ϫ10 6 c.p.m./ml. Filters were incubated singly at 42°C for 16-24 h with slight agitation. The filters were washed with four changes of 200 ml of 6ϫ SSPE, 0.1% SDS solution equilibrated at 42°C. A series of M13 phage DNAs mutated at a single position in the PstI site, 5Ј-CTGCAG-3Ј, was used to test the hybridization conditions. The filters were exposed to a phosphor screen for 24-72 h, and the phosphor screen was scanned on a PhosphorImager. Putative mutants were plaque-purified and analyzed by DNA sequencing as described above, using the '-40' M13 17-base sequencing primer that anneals at positions 6278-6294. A third method for mutation frequency determination allowed detection of one type of bp substitution occurring at position 6246 in the M13 genome, where a G:C→T:A transversion in the minus strand would result in a TGA (opal stop) codon in the reading frame of the β-galactosidase gene. Upon plating on an opal suppressor strain, E.coli NR8044, suppression of the TGA stop codon results in a pale-blue phenotype, which can be confirmed by sequencing.
Results
Analysis of ABP-modified M13 genomes
Modification of DNA by N-OAc-TFAAABP results in an adduct profile similar to the reaction of DNA with N-OH-ABP under acidic conditions (6, 12, 14) . M13mp10 DNAs containing 0, 1 and 5 lesions per 7-kb single-stranded genome were obtained, and M13mp10 RF DNAs with 0, 45 and 93 adducts per 7 kbp RF genome were produced. Upon analysis by agarose gel electrophoresis, the ss and RF DNAs migrated with their respective unmodified standards. Modified M13mp10 RF DNAs with 93 adducts/molecule was estimated to include less than one AP site per molecule.
Genotoxicity of ABP in ds and ss M13 genomes
Survival of M13 RF genomes modified by ABP declined with increasing levels of modification ( Figure 1A) . From the data in Figure 1A , the D 37 (number of lesions resulting in 37% survival) was estimated as 90, 45 and 25 ABP adducts per genome in uvr ϩ /mucAB, uvr ϩ and uvrA cells, respectively, without UV treatment of the host cells. Excision repair proficiency of the host cell enhanced survival, particularly at the highest level of modification. Treatment of host cells to induce SOS gene functions increased survival of ds genomes containing 93 ABP lesions per genome 2-fold; the presence of plasmid pGW16 coupled with UV treatment of the cells increased survival 6-fold, compared with untreated host cells. In excision repair-deficient (uvrA) cells, survival decreased to 2406 a greater extent than in excision repair proficient-cells, leading to the conclusion that the uvr ϩ excision repair system participates in the repair of ABP lesions in M13 RF DNA. When the uvrA host cells were induced for SOS gene functions by UV treatment, survival of ds M13 DNA containing 93 ABP residues per genome was not significantly increased. Transfection efficiency of ss genomes containing ABP was not increased substantially in uvr ϩ cells compared with uvrA cells, as expected due to the specificity of the uvr ϩ excision repair system for double-stranded DNA (37) .
Mutagenicity of ABP DNA lesions in double-stranded M13 genomes
The experimental system employed allowed manipulation of both excision repair and SOS processing, the former by choice of a wild-type or excision-repair deficient strain, and the latter, by (i) induction of the endogenous E.coli umuDC genes (together with a number of other cellular genes) by UV light (37), or (ii) expression of mucAB genes encoded by the pKM101 derivative pGW16 (24) , with increased expression after UV light treatment. In both excision repair deficient (uvrA) and proficient (uvr ϩ ) cells, the number of mutants scored increased with the level of modification of the genome (Figure 2A) . Mutation frequency increased when host cells were treated with UV light in order to induce SOS processing. Strikingly, in DL7 cells without SOS-induction, mutagenesis was not significantly increased over background. These results clearly indicate that, in DL7 cells, mutagenesis induced by ABP lesions is dependent on the SOS mutagenic processing of the adducts. In contrast, in DL7/pGW16 cells and in DL6 (uvrA) cells, the mutation frequency for ABP-modified DNA was elevated above buffer control levels without UV pretreatment of the host cells (data not shown) and increased further when SOS processing was induced.
Mutagenicity of ABP DNA lesions in single-stranded M13 genomes
In M13 single-stranded DNA, ABP adducts were more mutagenic than in double-stranded (ds) DNA. Frequency of mutations increased with SOS induction of the host (Table I; Figure 2B ); the greatest increase in mutation frequency was observed in UV-treated cells containing the plasmid pGW16. Since examination of mutagenesis by ABP lesions has never been carried out in single-stranded M13mp10 DNA, a partial mutational spectrum was determined by DNA sequence analysis of the purified individual mutant plaques (Figure 3) . The distinctive feature of this mutational spectrum was that the dG residue at position 6310 in the sequence, 5Ј-TGA-3Ј was the site of mutation for~25% of the observed base changes in ss DNA, and thus represents a putative hotspot for ABP mutagenesis in ss M13mp10 DNA. Assuming that mutagenesis is targeted to the site of the adduct, 80% of the mutations occurred at putative dG adduct sites. In SOS-induced DL7 and DL7/pGW16 cells, the primary mutation observed was G→T transversions, whereas both G→T and G→C mutations occurred with equal frequency in uninduced DL7 cells ( Figure  3 ). The average ABP lesion was calculated to be mutagenic 6.2% of the time in ss genomes containing five adducts transfected into DL7/pGW16 cells.
Site-specific mutagenesis experiments
Preparation of an adducted tetramer. The electrophilic derivative of ABP, N-OAc-ABP was prepared and reacted with , was subjected to fast atom bombardment mass spectrometry, and the negative ion spectrum for TG 8-ABP CA showed the major [M -H] -ion to be at the expected value of 1339. UV spectra of TG 8-ABP CA displayed a prominent absorbance shoulder at 310 nm, typical of C-8-arylamine substituted nucleotides, compared with TGCA. Digestion of TG 8-ABP CA to mononucleosides revealed no dG peak upon HPLC analysis, but instead an easily discernible novel peak with a retention time identical to that of an authentic dG 8-ABP standard. Electrophoretic analysis of the unmodified and modified tetramers following treatment with the same conditions (100°C, 5 min) used to produce ss genomes for mutagenesis assays showed that the samples contained no detectable impurities. Construction of modified M13 genomes. As described above, a site-specifically modified M13 genome containing the dG 8-ABP adduct at a unique PstI site 5Ј-CTGCAG-3Ј was constructed and characterized, using the strategy of ligation of a tetramer into gapped heteroduplex genomes (Figure 4) . The ligation efficiency for the adducted tetramer was 25% compared with 50% for the unmodified genome, which was comparable to previous results with GHD prepared using different methods (34) and can be contrasted with the higher efficiency (50%) observed when a tetramer containing O 6 -methylguanine was ligated at the PstI site of a phage genome (35) . The resulting genomes contained the adduct either at position 6245 in the Fig. 4 . Positioning of a single dG 8-ABP adduct at the unique PstI site in an M13mp19(ϩ) genome. M13mp19 (ϩ10) RF DNA was linearized at the unique BglII site and 5Ј dephosphorylated with CIP. This linearized, dephosphorylated DNA was heat denatured and annealed to denatured M13mp19 (ϩ6) RF DNA that had been digested with SmaI. These manipulations produced two forms of the M13mp10 gapped heteroduplex vectors (M13GHD), with a four base gap at the PstI site in either the (-) or the (ϩ) strand. An ABP-modified tetranucleotide, 5Ј-pTpG 8-ABP pCpA OH -3Ј was ligated to the M13GHD molecules, producing M13 genomes containing the dG 8-ABP adduct in the plus (ϩ) strand at position 6245 or the minus (-) strand at 6246. In parallel, a control genome was constructed with an unmodified tetranucleotide, 5Ј-pTpGpCpA-3Ј. Subsequently, the modified and unmodified genomes were heat denatured to produce the singly ABPadducted ss genome, M13-TG 8-ABP CA and the control ss genome, M13-TGCA. plus strand, or at position 6246 in the minus strand ( Figure  4 ). The DNA of the strand opposite the one containing the adduct was nicked, allowing preparation of single-stranded DNA containing a unique ABP lesion at the PstI site.
Site-specific mutagenesis studies with genomes containing the major ABP-DNA adduct
The ligated genomes were characterized by PstI restriction enzyme digestion ( Figure 5) , to confirm the localization of the adduct to this restriction site, as well as to determine if the adduct rendered the DNA refractory to PstI digestion. As expected, unmodified genome was linearized by PstI. In contrast, the radioactivity in the ABP-modified genomes comigrated with Form II DNA, indicating that the adduct had protected the genome from linearization with PstI. In another restriction mapping experiment, the question of whether the oligonucleotide had been ligated at both the 5Ј and the 3Ј end was addressed, and the results demonstrated (data not shown) that Ͼ95% of both the ABP-modified and modified genomes were joined at both termini. Consistent with this finding, it was determined that~50% of the DNA was present as ss circular genomes following denaturation by heating to 100°C and agarose gel analysis ( Figure 5 ). Analysis of either the modified tetramer (see above) or the modified genome ( Figure  5 ) indicated that the conditions utilized to release singlestranded DNA did not detectably alter the adduct or genome. Table II depicts the results of two independent mutation assays with an M13 genome containing a single dG 8-ABP (M13-TG 8-ABP CA) and the control genome, M13-TGCA. In order to maximize the sensitivity for mutant detection, electroporation was used for transfection of M13 genomes into host E.coli. Infective centers were enumerated to quantitate survival of the modified genome, and it is apparent that the transfection efficiency of the ABP-adducted genome was not significantly lower than the unmodified genomes in the uvr ϩ cells, with or without SOS induction or the presence of pGW16. This observation is comparable to the preceding random mutagenesis studies ( Figure 1B ) in that survival of phage M13 genomes containing one ABP lesion on average was Ͼ50% and that SOS-induction or the presence or absence of pGW16 had no effect on phage survival.
Genotoxicity and mutagenicity of a single ABP lesion in an M13 ss genome
Mutation frequency, defined as the fraction of progeny phage that was mutant and expressed as a percentage, was determined using one of three methods. The first method involved a PstI selection protocol, as initially described by Loechler et al. (21) . Progeny phage were grown from the transfections (T 1 ), and three rounds of PstI selection of DNA produced from the mutagenesis experiments were conducted. After the fourth round of transformation (T 4 ), mutant phage were purified and the DNA was sequenced, allowing calculation of mutation frequency (see Materials and methods and Table II ) either targeted to the site of the introduced lesion (positions 6245 or 6246), or untargeted (in the vicinity of the PstI site or at positions 6242, 6243, 6247 or 6248 of the PstI site). Total mutation frequency was the sum of the frequencies of targeted and untargeted mutations.
When mutations targeted to the lesions positioned in the PstI site are considered in an SOS-induced host, the mutation frequency for M13-TG 8-ABP CA genomes was 0.013% in experiment 1, compared with Ͻ0.0019% for M13-TGCA genomes (no mutant phage detected). To validate these results, further methods for determination of mutation frequency were applied (data not shown). Estimation of mutation frequency for M13-TG 8-ABP CA using a second method of quantitation, plaque hybridization, yielded a value of 0.007%, which is in reasonable agreement with the PstI selection method. A third method based on plaque color phenotype on strain E.coli NR8044, specific for G→T mutations at position 6246, led to a value of Ͻ0.01%, indicating that there was not a detectable mutation frequency over background for this transversion among phage originally classified as colorless when plated on E.coli GW5100. Consequently, three independent means of mutation frequency determination yield a value of~0.01% for a singly-adducted M13 genome containing the dG 8-ABP lesion. Targeted mutations were not observed in M13-TG 8-ABP CA genomes or in control M13-TGCA genomes replicated in non-SOS-induced cells in experiment 1. In experiment 2, the value for the M13-TG 8-ABP CA genomes replicated in DL/7 pGW16 treated with UV light was 0.016%, while the corresponding mutation frequency for control, M13-TGCA genomes was Ͻ0.0060% (Table II) .
An examination (Table III, Figure 6 ) of the targeted mutations observed in the sample sequenced from experiment 1, presumably induced by the ABP lesion, indicated that over 60% were G→C transversions, occurring with equal frequency from either the plus or the minus strand. Other mutations observed included G→T transversions and a G→A transition. It was not possible to establish the background of these mutations occurring in control experiments, since no mutant phage with base-pair substitution changes at positions 6245 or 6246 were observed. Indeed, among the PstI insensitive mutants examined from the M13-TGCA control transfections, no base-pair substitution change at any position of the ligated tetranucleotide was found. From this data, we infer that the dG 8-ABP adduct is capable of contributing to the predominant feature of mutational spectrum induced by ABP lesions in general: transversion mutations targeted to G residues.
In DL7/pGW16 cells treated with UV light, total mutation frequency in experiment 1, including detectable events not targeted to the adducted residue (untargeted mutation fre- Modified and unmodified DNA were electroporated into host cells induced or uninduced for SOS mutagenic processing. Mutation frequency (MF) was calculated after three rounds of PstI selection 1 (21, see Materials and methods). The targeted MF indicated the frequency of phage with base substitution changes at positions 6245 or 6246 ( Figure 6 ). The targeted MF data was confirmed using two other methods (see Results). Untargeted MF quantitated other DNA sequence changes that resulted in PstI resistance. n.d., not determined. a For example, to determine the targeted mutation frequency (MF) for M13-TG 8-ABP CA replicated in DL7/pGW16 ϩ UV cells (experiment 1) using the formula given in Materials and methods, 60 mutant ss DNAs were sequenced (seq B 4 ) following a total of four rounds of transformation with three rounds of PstI selection. Of this number, 24 were determined to be wild-type DNAs that apparently evaded PstI selection. From the remaining 36, 23 (M Un ) were found to be untargeted bp substitutions, insertions or deletions and the remaining 13 (M Tar ) were observed to be targeted bp substitutions. In this instance, B 4 was 0.2ϫ10 7 , C 4 was 9.5ϫ10 7 , C 1 was 0.17ϫ10 7 and T 1 was 6.1ϫ10 7 . Applying the formula MF ϭ (M Tar /seq B 4 )ϫ(B 4 /C 4 )ϫ(C 1 /T 1 )ϫ100 yielded a targeted MF of (0.22ϫ0.021ϫ0.028ϫ100) or 0.013%. For data points where no mutation was observed, M was assumed to be 1 in order to obtain an upper estimate of the MF. Mutants were selected by PstI digestion. Targeted mutations refer to those occurring at positions 6245 or 6246 (Figure 6 ), the position of modification for M13 TG 8-ABP CA genomes. Untargeted mutations refer to sequence changes not occurring at positions 6245 or 6246 that nonetheless rendered the phage DNA resistant to digestion by PstI. *DNA sequencing data from experiment 2 is not presented due to the high background of untargeted mutations, which were detected in both control and adduct-containing samples and cannot be distinguished from mutations caused by the genetic engineering techniques, as discussed by Bradley et al. (36) and references therein. (ϩ10) is illustrated. DNA sequence changes in phage from M13-TG 8-ABP CA genomes corresponding to base substitution mutations at the PstI site, position 6245 in the 'ϩ' strand and 6246 in the '-' strand, are depicted. In control genomes, no base substitution changes were located at these sites. quency), was 0.035% and 0.015% for M13-TG 8-ABP CA and M13-TGCA genomes respectively. In experiment 2, similar levels of targeted mutation frequency were observed in DL7/ pGW16 cells treated with UV light (see above), but untargeted mutation frequency was higher, elevating the total mutation frequency to 0.20% for M13-TG 8-ABP CA genomes and 0.078% for control M13-TGCA genomes. Untargeted mutations were also observed in the absence of SOS induction (DL7, UV, experiment 1), contributing to a total mutation frequency of 0.0048% for M13-TG 8-ABP CA genomes and 0.023% for M13-TGCA genomes. These untargeted mutations consisted primarily of insertions at the PstI site, both in samples from the control and adducted genome progeny (Table III, experiment  1) , with a number of -21 deletions also present. To a lesser extent, untargeted base substitutions also occurred within the PstI recognition site. Due to the nature of the untargeted mutational changes, the variability of frequency from experiment to experiment, and because these mutations were also detected in control samples, their probable origin is the genetic engineering techniques used to construct the modified and unmodified genomes. Insertions and deletions were not observed among ABP-induced mutations in the globallyadducted M13 single-stranded genomes (Figure 3) , again suggesting that they arose during the construction process in the site-specific mutagenesis experiments.
Discussion
In an earlier study from this laboratory, a single dG adduct present in one strand of a double-stranded M13 genome was found to cause a low or undetectable mutation frequency in E.coli (14) . A bias against replication of the ABP-adducted strand of the singly-modified vector was suggested as one explanation for this observation. Another factor likely to reduce the mutational efficiency is DNA repair, since most DNA repair processes function more effectively on double-stranded DNA (37) . Accordingly, other studies conducted in our laboratory indicated that several lesions, including O 6 -methylguanine, thymine glycol and the major G ∧ G adduct of cisplatin, exhibit elevated mutation frequencies when positioned in singlestranded rather than double-stranded DNA (36, 38, 39) .
These considerations led us to further investigate mutagenesis by the major adduct of ABP, dG 8-ABP , in an experimental system providing: (i) the flexibility of engineering lesions in single-stranded or double-stranded DNA; (ii) a highly sensitive method for measurement of mutation frequencies; and (iii) the ability to study site-specific or generalized mutagenesis. Two studies were undertaken. First, random mutagenesis assays using the lacZα gene as a target were performed to infer which of the known DNA adducts of ABP were mutagenic in the M13 ss genome and to compare the mutational spectrum in ss DNA with the results previously observed in ds DNA (14) . Second, site-specific mutagenesis experiments were conducted to determine and quantify the genotoxic and mutagenic effects of the major ABP DNA adduct in M13 ss DNA.
Mutagenesis studies in the lacZ gene of globally ABP-modified M13 genomes
Assays with both ABP-modified ss and ds genomes indicated a dose-dependence of the number of ABP adducts per genome with an increase in mutation frequency in both SOS-induced uvr ϩ and uvrA cells. SOS-induction of host cells substantially increases the mutagenic impact of ABP-lesions in M13 ds DNA (Figure 2A ). ABP adducts in M13 ss DNA are 50-fold more genotoxic than in M13 ds DNA (Figure 1 ). Excision repair proficiency of the host cell did not profoundly enhance the survival of ABP-modified ss DNA ( Figure 1B) .
Our investigation of the mutational specificity of ABP in the α fragment of the lacZ gene has shown that in this experimental system, mutations are largely dependent on SOS processing functions, as provided by UV induction of the host SOS response, the expression of the mucAB genes present on the pKM101 derivative pGW16 or a combination thereof. The 2411 DNA lesions caused by activated forms of this chemical are primarily base-pair substitutions (Figure 3) . In single-stranded DNA containing ABP lesions, mutational changes occurred primarily at G residues, with the predominant events being G→T transversions, followed by G→C transversions. Also detected were G→A transitions and an A→T transversion. A putative hotspot for mutagenesis at a guanine target was observed at position 6310 (Figure 3 ). There was significant concordance between the mutational spectrum observed in single-stranded DNA and double-stranded DNA (14) : guanines at positions 6259, 6314 and 6315 yielded mutations in both studies. The putative transversion hotspot at the A:T base pair at position 6357 (14) was not observed, implying that the target base had been adenine at this position in previous mutagenesis experiments that were carried out with ABPmodified double-stranded DNA. In another recent study of ABP mutagenesis (17) , the target was the tetracycline resistance gene of pBR322, with 22 mutant plasmids yielding 39 mutations. Three positions were represented by two or more independent mutants, but there was no particular mutational 'hotspot'. The primary mutations seen were G→T and G→C transversions, with one A→T transversion observed.
We and others have previously presented models for the transversions at G residues caused by dG 8-ABP (8) (9) (10) 14) . A syn conformation about the N-glycosidic bond in DNA may result in mispairing with dG during DNA synthesis, leading to G→C mutations; and mispairing with the imino form of dA would account for the observed G→T transversion mutations.
Mutagenesis studies in the PstI site of site-specifically ABPmodified M13 genomes
Because no mutations at the position of the ABP lesion were observed in control samples, it is reasonable to conclude that the mutations seen in the M13-TG 8-ABP CA genomes were induced by the dG 8-ABP lesion. The observed sequence changes were predominantly (69%) G→C transversions, with 23% G→T transversions and a single G→A transition ( Figure 6 ). This is in contrast to the globally-adducted mutagenesis studies, where G→T transversions were prevalent, possibly reflecting a sequence context effect for a dG 8-ABP lesion situated at position 6245 or 6246 for mispairing with dG or dA as described above. The untargeted mutations observed in control samples as well as M13-TG 8-ABP CA were considered to reflect background from the genetic manipulations required to prepare the genomes, although it is interesting to note that, in SOSinduced cells, untargeted mutation was increased~2-fold (Table  II) in genomes containing an ABP lesion.
It is important to consider the quantitative aspects of mutagenesis by site-specific dG 8-ABP lesions. As described above, the targeted mutation frequency at the PstI site in single-stranded M13 DNA for these lesions was no greater than 0.01%. In comparison with other single carcinogen-DNA lesions that have been examined in bacteriophage or plasmid systems, such as thymine glycol [0.2-0.4% (39)]; O 6 -methylguanine [0.4% (38) ]; 8-oxodG [0.5-1%, (40) ]; AFB 1 -N7-Gua [4%, (41) ] in M13 DNA, and dG C8-AAF at a NarI site hotspot in pBR322 [1%, (42) ], it is apparent that dG 8-ABP is 20-400-fold less mutagenic. Notwithstanding its ability to inhibit cleavage by the restriction enzyme PstI, and to reduce ligation efficiency by 50% when a TG 8-ABP CA tetramer is annealed to gapped heteroduplex molecules, it appears that a dG 8-ABP lesion localized to the PstI site is highly likely to function as a dG residue when encountered by the DNA replication apparatus, in the presence or absence of SOS mutagenic processing. In this regard, it is interesting that King et al. (43) reported that of four arylamine adducts examined in vitro, dG 8-ABP caused the least hesitation of DNA polymerase.
The value of~0.01% for the mutation frequency at the PstI site also contrasts with our estimations of mutational efficiency of the 'average' dG 8-ABP lesion in SOS-induced cells. In experiments employing single-stranded, globally-adducted M13 DNA, the average mutagenic efficiency (44) for an ABP lesion was 6.2%, a striking 600-fold increase over the rate of mutagenesis at the PstI site. Two factors may be contributing to this observation. One is an inherent lack of mutagenicity of the dG 8-ABP lesion, due to propensity for repair or a high likelihood to have the correct dC residue inserted opposite it by an oncoming DNA polymerase. Thus, this lesion may have been responsible for only a small portion of the mutagenesis observed in the global ABP-modification studies. An implication requiring further investigation is that one or more of the minor adducts is highly mutagenic. Another factor in the quantitative level of mutagenesis may be sequence context, affecting rate of DNA repair, extent of potentially mutagenic conformers capable of being fixed as point mutations by the DNA polymerase, or both. The latter aspect of mutagenesis by ABP has been investigated by Shapiro et al. (10) in computer modeling studies, which revealed stable competing conformers for dG . The minor groove conformer was hypothesized to enhance mispairing with dA or dG. Furthermore, the identity of the predominant conformer was proposed to be highly dependent on sequence context. Rate of DNA repair as a function of sequence context has not been evaluated for ABP lesions, although it is likely to be non-uniform, for example as observed with O 6 -methylguanine in the β-lactamase gene of pBR322 and UV lesions in the human p53 gene (45, 46) . As elucidated by Bichara and Fuchs (47) , at a 'mutation-prone sequence', the presence of an adduct may induce a change in the conformation of the DNA, generating a target for the proteins that process the lesion into a mutation.
It is instructive to correlate the results obtained with ABP adducts with the structurally related AF adducts (dG 8-AF lesions). AF adducts in ss DNA were of increased toxicity and mutagenicity in a study of M13 ss and ds DNA genomes (22) . In single-stranded DNA, a direct parallel can be drawn between the mutation frequency above background of 2.5ϫ 10 -3 in SOS-induced cells for five AF adducts/genome (22) , and 4.3ϫ10 -3 for five ABP adducts/genome found in this study; another report (43) lists a value of 5.6ϫ10 -3 for 20 ABP lesions in ss DNA. Global modification of the lacZα gene with AF residues resulted in similar frequencies of G→T, G→C and G→A mutations (22) . Although the profile of basepair substitutions seen is similar for these two types of lesions differing in structure only by a methylene bridge, significantly more frameshift mutations and deletion mutations were found in the AF study. It has been hypothesized that the lack of frameshift mutations caused by ABP is due to its non-planarity with the consequent reduction in amine-to-base stacking interactions (8) . The presence of deletion mutations in the AF study may be related to the use of JM103 cells containing the F'lacZ∆M15 mutation as the host cells for fixation of mutations. Fuchs and colleagues (42, 47, 48) have also investigated mutagenesis due to AF lesions in plasmid pBR322, and found that significant levels of mutation were seen only when SOSprocessing was induced in host cells. In experiments where 2412 site-specifically modified plasmids with AF lesions at the SpeI site with uracil residues in the strand opposite the adduct were introduced into E.coli, predominantly G→T transversions were observed, with a mutation efficiency of 2.9% (49) . Although these results are not directly comparable with the present study due to differences in the experimental systems, the 300-fold difference in MF in site-specific mutagenesis studies for the structurally similar AF and ABP lesions is noteworthy, especially since global mutagenesis studies in the M13 cloning vectors gave broadly similar quantitative results.
Aminobiphenyl-induced mutations considered in the context of mammalian carcinogenesis
The data from these experiments in microbial systems can be regarded in view of experiments conducted in B6C3F1 and CD-1 mice administered ABP (50) . In the former strain, ABP induced C→A mutations (reflecting G→T transversions in the non-coding strand) in H-ras codon 61 in 11 tumors, and G→C mutations in two other tumors concur with the data seen in this study, the previous study from this laboratory (14) and that of Melchior et al. (17) . In contrast, in CD-1 mice, A→T transversions in H-ras codon 61 were seen, which is congruent with evidence [herein and Lasko et al. (14) ] for mutagenesis at A residues as well. The species difference in the mutational spectrum at the oncogene may be related to the initial adduct pattern, adduct processing into mutations, or the differential selection of mutants imposed by the genetic background. From this perspective, it is conceivable that the ability of ABP lesions to induce a variety of mutations might strengthen the carcinogenicity of a relatively weak mutagen. Several groups have examined the spectrum of mutations in the p53 gene in smokers and non-smokers with bladder cancer (51) (52) (53) (54) (55) , and base substitutions have been found at G:C and A:T base pairs. Notably, two investigations (52,53) revealed that~30% of the total point mutations analyzed consisted of G:C→C:G transversions, the type of mutation that occurred most frequently when dG 8-ABP was located at the PstI site in ss M13 DNA and also seen in forward mutation assays in the lacZ gene (this study) and the pBR322 tet R gene (17) . ABP exposure is consistently detected in smoking and non-smoking human populations, and the available evidence in model systems indicates that ABP lesions can cause the types of mutation seen in tumors in target organs. Our results suggest that the major adduct of ABP is capable of contributing to the ABPinduced mutational spectrum. Estimation of the quantitative role of dG 8-ABP requires analysis in other sequence contexts. Further experimentation examining the other adducts is required to determine their relative mutagenic potency.
